1.36

0.00% 0.00

After Hours: 1.36

Acurx Pharmaceuticals Inc (ACXP)

Overview News Price History Option Chain Financials Discussions Forecast

Acurx Pharmaceuticals Inc stock is traded at $1.36, with a volume of 134.02K. It is up +0.00% in the last 24 hours and down -3.55% over the past month. Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Previous Close:

$1.36

Open:

$1.38

24h Volume:

134.02K

Relative Volume:

1.08

Market Cap:

$5.84M

Revenue:

Net Income/Loss:

$-7.50M

P/E Ratio:

-0.3088

EPS:

-4.4035

Net Cash Flow:

$-6.14M

1W Performance:

-2.16%

1M Performance:

-3.55%

6M Performance:

-68.15%

1Y Performance:

-66.17%

1-Day Range:

$1.35

$1.38

1-Week Range:

$1.305

$1.4098

52-Week Range:

$1.305

$8.34

Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile

Name

Acurx Pharmaceuticals Inc

Sector

Healthcare (1067)

Industry

Biotechnology (595)

Phone

917-533-1469

Address

259 LIBERTY AVENUE, STATEN ISLAND

Employee

Twitter

Next Earnings Date

2026-11-11

Latest SEC Filings

ACXP's Discussions on Twitter

Compare ACXP vs VRTX, REGN, MRNA, ARGX, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACXP Acurx Pharmaceuticals Inc	1.36	5.84M	0	-7.50M	-6.14M	-4.4035
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Acurx Pharmaceuticals Inc Stock (ACXP) Latest News

Sep 20, 2026

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's Why - Eastern Progress

Sep 20, 2026

Sep 19, 2026

New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global - Eagle-Tribune

Sep 19, 2026

Sep 18, 2026

Acurx Pharmaceuticals (NASDAQ: ACXP) May Generate Up to $2.8M Through Lincoln Park Capital Share Sales - Kalkine Media

Sep 18, 2026

Acurx Pharmaceuticals Q2FY26 Results: Net loss widens 4.5% to $2.3 million - scanx.trade

Sep 18, 2026

Transcript: Acurx Pharmaceuticals Q2 2026 Earnings Conference Call - Benzinga

Sep 18, 2026

Acurx Pharmaceuticals, Inc. SEC Filing (Sep 18, 2026) - Stock Titan

Sep 18, 2026

Sep 08, 2026

Acurx Pharmaceuticals files prospectus for $1.5 million SEC offering - scanx.trade

Sep 08, 2026

1.5M-share resale puts dilution on table at Acurx (ACXP). How much cash can it still tap? - Stock Titan

Sep 08, 2026

Sep 01, 2026

Acurx Pharmaceuticals, Inc. SEC Filing (Sep 1, 2026) - Stock Titan

Sep 01, 2026

Aug 24, 2026

Acurx (ACXP) Q1 2026 Earnings: Profit Per Share Clears Its Benchmark for the Current Session; After Earnings: The Market Price Moves 1.38% Higher in the Latest ReadingProfit Growth Outlook - dars.gov.et

Aug 24, 2026

Aug 20, 2026